Eli Lilly LLY announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended approving its ...

Insights, Trends, Opportunities, and Recent DevelopmentsNew York, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Market Overview The global gastroenterology market is projected to reach USD 38.5 billion by 2024 ...

Committee for Medicinal Products for Human Use (CHMP) has recommended Eli Lilly’s Omvoh (mirikizumab) for approval in the ...

Crohn’s & Colitis UK are delighted to be awarded a grant of $638,000 from The Leona M. and Harry B. Helmsley Charitable Trust ...

ORLANDO -- A considerable amount of variability exists in surgical management of ileosigmoid fistulas in Crohn's disease (CD) ...

Gavin Anumene, a fan of anime, Lego and video games — as is right and proper at age 8 — has already logged more time in a ...

The Helmsley Charitable Trust issued a $3,035,566 grant to three researchers to explore the effects of GLP-1s, including Ozempic and Wegovy, on patients with Crohn’s disease. The effort will be led by ...

Inflammatory bowel disease (IBD) is a chronic inflammation of the digestive tract. It includes conditions such as ulcerative colitis and Crohn’s disease. People with IBD may experience persistent symp ...

Thankfully, the drug price reforms in the Inflation Reduction Act respond to the needs of millions of patients like myself ...

(RTTNews) - Eli Lilly and Company (LLY) Friday said that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Omvoh for the treatment ...

Merck & Co.’s kidney cancer drug Welireg, Bayer and BridgeBio’s transthyretin amyloid cardiomyopathy (ATTR-CM) therapy, and ...

Eli Lilly (NYSE: LLY) has received a positive recommendation for approval from European regulators for its drug Omvoh in the ...